Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
11.65
-0.27 (-2.27%)
Jul 29, 2026, 4:00 PM EDT - Market closed
Viemed Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 286.57 | 270.28 | 224.26 | 183.01 | 138.83 | 117.06 | |
Revenue Growth | 23.10% | 20.52% | 22.54% | 31.82% | 18.60% | -10.85% |
Cost of Revenue | 121.56 | 114.82 | 91.05 | 70.23 | 54.15 | 43.65 |
Gross Profit | 165.01 | 155.46 | 133.2 | 112.78 | 84.68 | 73.41 |
Selling, General & Admin | 137.01 | 130.5 | 112.48 | 93.73 | 73.36 | 60.04 |
Depreciation & Amortization Expenses | 1.53 | 1.49 | 1.48 | 1.39 | 1.01 | 0.85 |
Research & Development | 2.8 | 3.02 | 3.07 | 2.78 | 2.7 | 2.11 |
Other Operating Expenses | 0.27 | -2.49 | -1.73 | 0.55 | -0.64 | -1.17 |
Total Operating Expenses | 141.6 | 132.51 | 115.3 | 98.45 | 76.43 | 61.83 |
Operating Income | 23.4 | 22.95 | 17.9 | 14.33 | 8.25 | 11.58 |
Interest Income | - | - | -0.95 | 0.49 | 0.94 | 1.24 |
Interest Expense | 0.7 | 1.18 | 0.78 | 0.42 | 0.2 | 0.32 |
Total Non-Operating Income (Expense) | 0.7 | 1.18 | -0.18 | 0.91 | 1.13 | 1.56 |
Pretax Income | 22.1 | 21.77 | 16.17 | 14.39 | 8.99 | 12.5 |
Provision for Income Taxes | 6.72 | 6.39 | 4.76 | 4.15 | 2.77 | 3.38 |
Net Income | 15.38 | 15.38 | 11.41 | 10.24 | 6.22 | 9.13 |
Minority Interest in Earnings | 0.49 | 0.44 | 0.14 | - | - | - |
Net Income to Common | 14.89 | 14.93 | 11.27 | 10.24 | 6.22 | 9.13 |
Net Income Growth | 21.19% | 32.57% | 9.98% | 64.63% | -31.82% | -71.06% |
Shares Outstanding (Basic) | 39 | 39 | 39 | 38 | 39 | 39 |
Shares Outstanding (Diluted) | 41 | 41 | 41 | 40 | 40 | 41 |
Shares Change | -1.37% | 0.05% | 1.05% | 1.44% | -2.15% | 0.38% |
EPS (Basic) | 0.39 | 0.38 | 0.29 | 0.27 | 0.16 | 0.23 |
EPS (Diluted) | 0.37 | 0.37 | 0.28 | 0.25 | 0.16 | 0.22 |
EPS Growth | 23.33% | 32.14% | 12.00% | 56.25% | -27.27% | -71.80% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 25.92 | 11.93 | 1.32 | 19.12 | 4.85 | 2.75 |
Free Cash Flow Growth | - | 805.24% | -93.11% | 294.21% | 76.30% | -87.53% |
Free Cash Flow Per Share | 0.64 | 0.29 | 0.03 | 0.47 | 0.12 | 0.07 |
Gross Margin | 57.58% | 57.52% | 59.40% | 61.63% | 60.99% | 62.71% |
Operating Margin | 8.17% | 8.49% | 7.98% | 7.83% | 5.94% | 9.89% |
Profit Margin | 5.37% | 5.69% | 5.09% | 5.60% | 4.48% | 7.80% |
FCF Margin | 9.04% | 4.41% | 0.59% | 10.45% | 3.49% | 2.35% |
EBITDA | 53.03 | 51.56 | 43.27 | 36.19 | 23.88 | 22.89 |
EBITDA Margin | 18.50% | 19.08% | 19.29% | 19.78% | 17.20% | 19.56% |
EBIT | 23.4 | 22.95 | 17.9 | 14.33 | 8.25 | 11.58 |
EBIT Margin | 8.17% | 8.49% | 7.98% | 7.83% | 5.94% | 9.89% |
Effective Tax Rate | 30.40% | 29.36% | 29.44% | 28.82% | 30.79% | 27.01% |